Home
Who we are
Why we exist
In the news
The Experts speak
> Henry McCandless
>
> Arthur Schafer
Upcoming events
How to help
|
The Experts Speak
Citizen Audit of Responsibilities, Performance and
Accountabilities in the Apotex Inc. Influence Issue at The University
of Toronto's Hospital for Sick Children, 1996-1999.
- A Report by the Alliance for Public Accountability, February 2000.
|
SUMMARY
Main Message
Summary Audit Observations
Summary Recommendation
General Observations
Specific Recommendations |
|
|
I.
II.
III.
IV.
V.
VI.
VII.
VIII.
IX.
X.
XI.
XII.
XIII.
|
THE REPORT
Introduction to Citizen Audit
Introduction to the APA report
Purpose of
the Report
Who
Had What Responsibilities and Accountabilities?
Basic
Principles and Concepts Used in the Report
The
precautionary principle
The principle of directing-mind
responsibility
The principle of self-informing
The principle of management control
The concepts of responsibility and
accountability
The concept of public accountability
What Happened at the Hospital
Government
policy affecting research
The deferiprone
(L1) research
Warning signs
Apotex's action
The disclosure
issue
Hospital
officials' and Board's response
The Naimark
consulting assignment
January 1999
events
Board of Trustees responsibilities, Performance
and Answering
Board of
Trustees Responsibilities
Board of
Trustees Performance
Board of Trustees
Answering
Hospital Executive Responsibilities, Performance
and Answering
Executive
Responsibilities
Executive
Performance
Executive
Answering
Senior Medical research Officials Responsibilities,
Performance and Answering
Research Officials
Responsibilities
Research
Officials Performance
Research
Officials Answering
Researchers Responsibilities, Performance
and Answering
Researchers
Responsibilities
Researchers
Performance
Researchers
Answering
University of Toronto Responsibilities,
Performance and Answering
University
Responsibilities
University
Performance
University
Answering
Health Protection Branch Responsibilities,
Performance and Answering
Health Protection
Branch Responsibilities
HPB responsibilities related to the
Toronto Deferiprone trial
Minister's responsibilities in funding
and safety policy
Health Protection
Branch Performance
HPB performance in safety-based policy
for drugs
HPB performance in the deferiprone trial
Health Protection
Branch Answering
Medical Research Council Responsibilities,
Performance and Answering
Medical Research
Council (MRC) Responsibilities
MRC responsibilities in research funding
policy
MRC responsibilities in the deferiprone
trial
Medical Research
Council Performance
MRC performance in research funding policy
MRC performance related to the Toronto
clinical trial
Medical Research
Council Answering
Apotex's Responsibilities, Performance
and Answering
Apotex's
Responsibilities
Apotex's
Performance
Apotex's
Answering
Epilogue: Events Subsequent to 25 January
1999
Hospital
and University Officials' Actions
The Harassment
Mail Issue
Statements
Made in January-February 2000
Conclusion |
|
|
|
APPENDICES
Appendix 1 Principles of Effective
Governance
Appendix 2 Observations on the
Naimark Consulting Assignment
Appendix 3 The University President's
25 January 1999 Agreement
Appendix 4 Deferiprone in Europe
in 1999 |
|